The synthetic lethality of ARID1A and AURKA was verified in three different ARID1A isogenic CRC pairs and three ovarian cancer cell lines with different ARID1A statuses; however, the synthetic lethality in ovarian cancer cells needs to be further investigated. This evidence concerns the gene AURKA and ovarian carcinoma.